Skip to main content

Giant-Cell Tumour of Bone (GCT)

  • Reference work entry
  • First Online:
European Surgical Orthopaedics and Traumatology

Abstract

Giant-cell tumour of the bone (GCT) is an aggressive, benign lesion with a high rate of local recurrence. Ten percent undergo malignant transformation and 1–4 % give pulmonary metastases even when the histological appearance is benign. Local oncological control (recurrence rate of 0–5 %) is best achieved by en bloc resection of the GCT with normal tissue, which means sacrificing the joint in most cases because of the epiphyseal location of the tumour. Curettage of the defect is therefore the initial treatment of choice. The high rate of recurrence of 20–50 % can be decreased by using different adjuvants such as phenol, bone cement or liquid nitrogen, etc. The indications for curettage and resection are discussed and the various possibilities for reconstruction of the defects in different sites are described. Disease-free survival can be achieved in 96–100 % by adequate treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 649.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 949.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Anract P, De-Piueus G, Cottias P, Puillart P, Forest M, Tomeno B. Malignant giant-cell tumor of bone. Clinico-pathological types and prognosis: a review of 29 cases. Int Orthop. 1998;22:19–26.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Antal I, Sápi Z, Szendrői M. The prognostic significance of DNA cytophotometry and proliferation index (Ki-67) in giant cell tumors of bone. Int Orthop. 1999;23:315–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J, Gosheger G. Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Clin Oncol. 2008;134:969–78.

    Article  CAS  Google Scholar 

  4. Becker WT, Dohle J, Bernd L, Braun A, Cserháti M, Enderle A, Hovy L, Matejovsky Z, Szendrői M, Trieb K, Tunn PU. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Joint Surg Am. 2008;90-A:1060–7.

    Google Scholar 

  5. Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS. Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am. 1999;81-A:811–20.

    Google Scholar 

  6. Breitenseher M, Dominkus M, Scharitzer M, et al. Diagnostic imaging of giant-cell tumours. Radiologe. 2001;41:568–76.

    Article  CAS  PubMed  Google Scholar 

  7. Bridge JA, Mouron BJ, Neff JR, Bhatia PS. Significance of chromosomal abnormalities in a malignant giant cell tumor of bone. Cancer. 1991;57:87–92.

    CAS  Google Scholar 

  8. Campanacci M, Capanna R, Fabbri N, Bettelli G. Curettage of giant cell tumor of bone. Reconstruction with subchondral grafts and cement. Chir Organi Mov. 1990;75 (Suppl 1):212–3.

    CAS  PubMed  Google Scholar 

  9. Campanacci M, Giunti A, Olmi R. Giant-cell tumours of bone: a study of 209 cases with long term follow up in 130. Ital J Orthop Traumatol. 1975;1:249–77.

    Google Scholar 

  10. Capanna R, Fabbri N, Bettelli G. Curettage of giant cell tumor fo bone. The effect of surgical technique and adjuvants on local recurrence rate. Chir Org Mov. 1990;75 (Suppl 1):206–8.

    CAS  Google Scholar 

  11. Chakravarti A, Spiro IJ, Hug EB, Mankin HJ, Efird JT, Suit HD. Megavoltage radiation therapy for axial and inoperable giant-cell tumor of bone. J Bone Joint Surg Am. 1999;81-A:1566–73.

    Google Scholar 

  12. Chen TH, Su YP, Chen WM. Giant cell tumors of the knee: subchondral bone integrity affects the outcome. Int Orthop. 2005;29:30–4.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Cheng CY, Shih H-N, Hsu KY, Hsu RWW. Treatment of giant cell tumor of the distal radius. Clin Orthop. 2001;383:221–8.

    Article  PubMed  Google Scholar 

  14. Cheng JC, Johnston JO. Giant-cell tumor of bone: prognosis and treatment of pulmonary metastases. Clin Orthop. 1997;338:205–14.

    Article  PubMed  Google Scholar 

  15. Clohisy DR, Vorlicky L, Oegema Jr TR, Snover D, Thompson RC. Histochmical and immonohistochemical characterization of cells constituting the giant cell tumor of bone. Clin Orthop. 1993;287:259–65.

    PubMed  Google Scholar 

  16. Dominkus M, Ruggieri P, Bertoni F, Briccoli A, Picci P, Rocca M, Mercuri M. Histologically verified lung metastaes in benign giant cell tumours – 14 cases from a single institution. Int Orthop. 2006;30:499–504.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Eckhardt JJ, Grogan TJ. Giant cell tumor of bone. Clin Orthop. 1986;204:45–58.

    Google Scholar 

  18. Enneking WF. Musculoskeletal tumor surgery. New York: Churchill Livingston; 1983. p. 613–86, 1435, 399–403.

    Google Scholar 

  19. Gitelis S, Mallin AB, Piasecki P, Turner F. Intralesional excision compared with en bloc resection for giant-cell tumors of bone. J Bone Joint Surg Am. 1993;75-A:1648–55.

    Google Scholar 

  20. Hsu RWW, Wood MB, Sim FH, Chao EYS. Free vascularised fibular grafting for reconstruction after tumour resection. J Bone Joint Surg Br. 1997;79-B:36–42.

    Article  Google Scholar 

  21. Kivioja AH, Blomgvist C, Hietaniemi K, Trovik C, Walloe A, Bauer HC, Jorgensen PH, Bergh P, Folleras G. Cement is recommended in intralesional surgery of giant cell tumors: a scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop. 2008;79:86–93.

    Article  PubMed  Google Scholar 

  22. Komiya S, Sasaguri Y, Inoue A, et al. Characterization of cells cultured from human giant-cell tumors of bone: phenotypic relationship to the monocyte-macrophage and osteoclast. Clin Orthop. 1990;258:304–9.

    PubMed  Google Scholar 

  23. Labs K, Perka C, Schmidt GR. Treatment of stages 2 and 3 giant-cell tumor. Arch Orthop Trauma Surg. 2001;121:83–6.

    Article  CAS  PubMed  Google Scholar 

  24. Lackman RD, Hosalkar HS, Ogilvie CM, Torbert JT, Fox EJ. Intralesional curettage for grades II and III giant cell tumors of bone. Clin Orthop. 2005;438:123–7.

    Article  PubMed  Google Scholar 

  25. Lau YS, Sabokbar A, Gibbons CLMH, Giele H, Athanasou N. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Hum Pathol. 2005;36:945–54.

    Article  CAS  PubMed  Google Scholar 

  26. Leeson MC, Lippitt SB. Thermal aspects of the use of polymethylmethacrylate in large methaphyseal defects in bone. Clin Orthop. 1993;295:239–45.

    PubMed  Google Scholar 

  27. Leggon RE, Zlotecki R, Reith J, Scarborough MT. Giant cell tumor of the pelvis and sacrum. Clin Orthop. 2004;423:196–207.

    Article  PubMed  Google Scholar 

  28. Malawer MM, Bickels J, Meller J, Buch RG, Henshow RM. Cryosurgery in the treatment of giant cell tumor. A long-term follow up. Clin Orthop. 1999;359:176–88.

    Article  PubMed  Google Scholar 

  29. Malek F, Krueger P, Hatmi ZN, Malayeri AA, Faezipour H, O’Donell RJ. Local control of long bone giant cell tumour using curettage, burring and bone grafting without adjuvant therapy. Int Orthop. 2006;30:495–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Malone S, O’Sullivan B, Catton C, et al. Long-term follow-up of efficacy and safety of megavoltage radiotherapy in high-risk giant cell tumors of bone. Int J Radiat Oncol Biol Phys. 1995;33:689–94.

    Article  CAS  PubMed  Google Scholar 

  31. Mankin HJ, Gebhardt MC, Jennings LC, Springfield DS, Tomford WW. Long-term results of allograft replacement in the management of bone tumors. Clin Orthop Relat Res. 1996;324:86–97.

    Article  PubMed  Google Scholar 

  32. Marcove RC, Sheth DS, Brien EW, Huvos AG, Healey JH. Conservative surgery for giant cell tumors of the sacrum. The role of cryosurgery as a supplement to curettage and partial excision. Cancer. 1994;74:1253–60.

    Article  CAS  PubMed  Google Scholar 

  33. Marcove RC. A 17-year review of cryosurgery in the treatment of bone tumors. Clin Orthop. 1982;163:231–4.

    PubMed  Google Scholar 

  34. Masui F, Ushigome S, Fujii K. Giant cell tumour of bone: a clinicopathologic study of prognostic factors. Pathol Int. 1998;48:723–9.

    Article  CAS  PubMed  Google Scholar 

  35. McDonald DJ, Sim FH, McLeod RA, Dahlin DC. Giant cell tumor of bone. J Bone Joint Surg Am. 1986;68-A:235–42.

    Google Scholar 

  36. Merle D’Aubigné R, Dejouany JP. Diaphyso-epiphyseal resection for bone tumour at the knee. With reports of nine cases. Clin Chir Orthop Réparatrice. 1958;40-B:385–95.

    Google Scholar 

  37. Mittermayer F, Krepler P, Dominkus M, Schwameis E, Sluga M, Heinzl H, Kotz R. Long-term followup of uncemented tumor endoprostheses for the lower extremity. Clin Orthop Releat Res. 2001;388:167–77.

    Article  Google Scholar 

  38. Miyamoto N, Higuchi Y, Tajima M, et al. Spindle-shaped cells derived from giant-cell tumor of bone support differentation of blood monocytes to osteoclast-like cells. J Orthop Res. 2000;18:647–54.

    Article  CAS  PubMed  Google Scholar 

  39. Moskovszky L, Szuhai K, Krenács T, et al. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analyis. Genes Chromosomes Cancer. 2009;48(6):468–79.

    Article  CAS  PubMed  Google Scholar 

  40. O’Donell RJ, Springfield DS, Motwani HK, Ready JE, Gebhardt MC, Mankin HJ. Recurrence of giant-cell tumors of long bones after curettage and packing with cement. J Bone Joint Surg Am. 1994;76-A:1927–33.

    Google Scholar 

  41. Ozaki T, Liljenqvist U, Halm H, Hillmann A, Gosheger G, Winkelmann W. Giant cell tumor of the spine. Clin Orthop Relat Res. 2002;401:194–201.

    Article  PubMed  Google Scholar 

  42. Prosser GH, Baloch KG, Tillmann RM, Carter SR, Grimer RJ. Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone? Clin Orthop. 2005;435:211–8.

    Article  PubMed  Google Scholar 

  43. Puri A, Agarwal MG, Shah M, Jambhekar NA, Anchan C, Behle S. Giant cell tumor of bone in children and adolescents. J Pediatr Orthop. 2007;27:635–9.

    Article  PubMed  Google Scholar 

  44. Quint U, Müller RT, Müller G. Characteristics of phenol. Arch Orthop Trauma Surg. 1998;117:43–6.

    Article  CAS  PubMed  Google Scholar 

  45. Rock M. Currettage of giant cell tumor of bone: factors influencing local recurrences and metastasis. Chir Organi Mov. 1990;75 (Suppl 1):204–5.

    CAS  PubMed  Google Scholar 

  46. Rödl RW, Gosheger G, Gebert C, Lindner N, Ozaki T, Winkelmann W. Reconstruction of the proximal humerus after wide resection of tumours. J Bone Joint Surg Br. 2002;84-B:1004–8.

    Article  Google Scholar 

  47. Schwartz LH, Okunieff PG, Rosenberg A, Suit HD. Radiation therapy in the treatment of difficult giant cell tumors. Int J Radiat Oncol Biol Phys. 1989;17:1085–8.

    Article  CAS  PubMed  Google Scholar 

  48. Suit H, Spiro I. Radiation treatment of benign mesenchymal disease. Semin Radiat Oncol. 1999;9:171–8.

    Article  CAS  PubMed  Google Scholar 

  49. Szalay K, Antal I, Kiss J, Szendrői M. Comparison of the degenerative changes in weight-bearing joints following cementing or grafting techniques in giant cell tumour patients: medium-term results. Int Orthop. 2006;30:505–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  50. Szendrői M. Giant-cell tumour of bone. J Bone Joint Surg Br. 2004;86-B:5–12.

    Google Scholar 

  51. Szendrői M, Antal I, Perlaky G. Mid-foot reconstruction following involvement of five bones by giant cell tumor. Skeletal Radiol. 2000;29:664–7.

    Article  PubMed  Google Scholar 

  52. Szendrői M. Giant-cell tumor in the radius: aggressiveness and soft-tissue recurrence. Chir Organi Mov. 1990;75:241–3.

    PubMed  Google Scholar 

  53. Trieb K, Bitzan P, Lang S, Dominkus M, Kotz R. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy. Eur J Surg Oncol (EJSO). 2001;27:200–2.

    Article  CAS  Google Scholar 

  54. Turcotte RE, Wunder JS, Isler MH, Bell RS, Schachar N, Masri BA, Moreau G, Davis AM. Giant cell tumor of long bone: a Canadian Sarcoma Group Study. Clin Orthop. 2002;397:248–58.

    Article  PubMed  Google Scholar 

  55. Ward WG, Li G. Customized treatment algorithm for giant cell tumor of bone: report of a series. Clin Orthop. 2002;397:259–70.

    Article  PubMed  Google Scholar 

  56. Wulling M, Engels C, Jesse N, et al. The nature of giant cell tumor of bone. J Cancer Res Clin Oncol. 2001;127:467–74.

    Article  CAS  PubMed  Google Scholar 

  57. Zhen W, Yaotian H, Songjian L, Ge L, Qingliang W. Giant-cell tumour of bone. The long-term results of treatment by curettage and bone graft. J Bone Joint Surg Br. 2004;86-B:212–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Miklós Szendrői .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 EFORT

About this entry

Cite this entry

Szendrői, M. (2014). Giant-Cell Tumour of Bone (GCT). In: Bentley, G. (eds) European Surgical Orthopaedics and Traumatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-34746-7_186

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-34746-7_186

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-34745-0

  • Online ISBN: 978-3-642-34746-7

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics